MaxCyte, Inc.MXCTNASDAQ
Loading
| Metric | Dec 20 | Dec 21 | Dec 22 |
|---|---|---|---|
| Revenue | 26 | 34 | 44 |
| Gross Profit | 23 | 30 | 39 |
| Operating Income | -11 | -18 | -27 |
| Net Income | -12 | -19 | -24 |
| EBITDA | -10 | -17 | -25 |
| EPS Diluted | -0.18 | -0.22 | -0.19 |
| Metric | Dec 20 | Dec 21 | Dec 22 |
|---|---|---|---|
| Cash & Equivalents | 19 | 48 | 11 |
| Total Current Assets | 45 | 270 | 252 |
| Total Assets | 52 | 284 | 287 |
| Total Current Liabilities | 12 | 16 | 15 |
| Total Liabilities | 19 | 21 | 33 |
| Total Equity | 33 | 263 | 254 |
| Total Debt | 7 | 6 | 16 |
| Net Debt | -12 | -42 | 5 |
| Metric | Dec 20 | Dec 21 | Dec 22 |
|---|---|---|---|
| Operating Cash Flow | -9 | -11 | -15 |
| Capital Expenditure | -2 | -4 | -18 |
| Free Cash Flow | -11 | -15 | -33 |
| Stock-Based Comp | 2 | 8 | 0 |
| Net Change in Cash | 4 | 29 | -37 |